P68400 CSK21_HUMAN
Gene name: CSNK2A1
Protein name: Casein kinase II subunit alpha
List of molecules and drugs that target protein P68400
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P68400_DB00171 | DB00171 | ATP | n/a | ZKHQWZAMYRWXGA-KQYNXXCUSA-N | NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O | |
2 | P68400_DB01765 | DB01765 | (5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid | n/a | Ki(nM) = 170.0 IC50(nM) = 390.0 | INSBKYCYLCEBOD-UHFFFAOYSA-N | OC(=O)CC1=C2NC(=O)C3=CC=CC=C3N2C2=C1C=CC=C2 |
3 | P68400_DB02170 | DB02170 | 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One | n/a | Ki(nM) = 780.0 | ZOHCDJRFYXKEQW-UHFFFAOYSA-N | OC1=CC=C(C2=C1C(=O)C1=C(O)C=CC=C1O2)[N+]([O-])=O |
4 | P68400_DB02709 | DB02709 | Resveratrol | n/a | LUKBXSAWLPMMSZ-OWOJBTEDSA-N | OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1 | |
5 | P68400_DB03035 | DB03035 | 1,8-Di-Hydroxy-4-Nitro-Anthraquinone | n/a | Ki(nM) = 800.0 | RIYCICFDXLNQPV-UHFFFAOYSA-N | OC1=CC=CC2=C1C(=O)C1=C(O)C=CC(=C1C2=O)[N+]([O-])=O |
6 | P68400_DB03127 | DB03127 | Benzamidine | n/a | PXXJHWLDUBFPOL-UHFFFAOYSA-O | NC(=[NH2+])C1=CC=CC=C1 | |
7 | P68400_DB03924 | DB03924 | 5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone | n/a | QVEMRPAUHFWHRV-UHFFFAOYSA-N | NC1=CC=C(N)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O | |
8 | P68400_DB04216 | DB04216 | Quercetin | n/a | Ki(nM) = 1180.0 | REFJWTPEDVJJIY-UHFFFAOYSA-N | OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1 |
9 | P68400_DB04395 | DB04395 | Phosphoaminophosphonic Acid-Adenylate Ester | n/a | PVKSNHVPLWYQGJ-FCIPNVEPSA-N | NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O | |
10 | P68400_DB04462 | DB04462 | Tetrabromo-2-Benzotriazole | n/a | OMZYUVOATZSGJY-UHFFFAOYSA-N | [H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br | |
11 | P68400_DB04719 | DB04719 | DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE | n/a | Ki(nM) = 40.0 | SLPJGDQJLTYWCI-UHFFFAOYSA-N | CN(C)C1=NC2=C(Br)C(Br)=C(Br)C(Br)=C2N1 |
12 | P68400_DB04720 | DB04720 | S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE | n/a | ZIGJZZDDPXRGTL-UHFFFAOYSA-N | CSC1=NC2=C(N1)C(Br)=C(Br)C(Br)=C2Br | |
13 | P68400_DB04721 | DB04721 | N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE | n/a | QHCZROILDUNGRT-UHFFFAOYSA-N | CN1CCN2C1=NC1=C(Br)C(Br)=C(Br)C(Br)=C21 | |
14 | P68400_DB07715 | DB07715 | Emodin | n/a | Ki(nM) = 1500.0 IC50(nM) = 580.0 | RHMXXJGYXNZAPX-UHFFFAOYSA-N | CC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1 |
15 | P68400_DB07802 | DB07802 | 3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE | n/a | MSOLROYRAHCJNK-UHFFFAOYSA-N | CC1=C(Br)C(=O)OC2=C(Br)C(O)=CC=C12 | |
16 | P68400_DB08338 | DB08338 | 19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one | n/a | HIJNSOUPEZHEMC-UHFFFAOYSA-N | O=C1CCCCC2=C3N=C(NC4=CC(N1)=CC=C4)N=C(NC1CC1)N3N=C2 | |
17 | P68400_DB08340 | DB08340 | N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE | n/a | LLYYAUZAGCZEKV-UHFFFAOYSA-N | N(C1=CC=CC=C1)C1=NC2=CC=NN2C(NC2=CC=CC=C2)=N1 | |
18 | P68400_DB08345 | DB08345 | 4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE | n/a | Ki(nM) = 137.0 | IWUUKHQIKFHWIW-UHFFFAOYSA-N | N#CC1=C2N=C(NC3=CC=CC=C3)N=C(NCCC3=CN=CN3)N2N=C1 |
19 | P68400_DB08353 | DB08353 | 2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE | n/a | Ki(nM) = 8.0 | NCVMTHVSAJMOPI-UHFFFAOYSA-N | N#CC1=C2N=C(NCC3CCCCC3)N=C(NC3=CC=CC=C3)N2N=C1 |
20 | P68400_DB08354 | DB08354 | 2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE | n/a | Ki(nM) = 5.0 | QCVULERVJOYHCP-UHFFFAOYSA-N | ClC1=CC=C(CNC2=NC3=C(C=NN3C(NC3=CC=CC=C3)=N2)C#N)C=C1 |
21 | P68400_DB08360 | DB08360 | 2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE | n/a | Ki(nM) = 24.0 | BIFHJPUTQBOBGJ-UHFFFAOYSA-N | CCN1CCN(CC1)C1=NC2=C(C=NN2C(NC2=CC=CC=C2)=N1)C#N |
22 | P68400_DB08362 | DB08362 | N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE | n/a | Ki(nM) = 0.35 | QVKXQLGRDOMAGC-UHFFFAOYSA-N | CC(=O)NC1=CC=CC(NC2=NC3=C(C=NN3C(NC3=CC=CC=C3)=N2)C#N)=C1 |
23 | P68400_DB08473 | DB08473 | Dichlororibofuranosylbenzimidazole | n/a | Ki(nM) = 4500.0 IC50(nM) = 13000.0 | XHSQDZXAVJRBMX-DDHJBXDOSA-N | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=CC(Cl)=C(Cl)C=C12 |
24 | P68400_DB08660 | DB08660 | Quinalizarin | n/a | Ki(nM) = 60.0 IC50(nM) = 110.0 | VBHKTXLEJZIDJF-UHFFFAOYSA-N | OC1=CC=C(O)C2=C1C(=O)C1=C(C(O)=C(O)C=C1)C2=O |
25 | P68400_DB08846 | DB08846 | Ellagic acid | inhibitor | AFSDNFLWKVMVRB-UHFFFAOYSA-N | OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2 | |
26 | P68400_DB12010 | DB12010 | Fostamatinib | inhibitor | GKDRMWXFWHEQQT-UHFFFAOYSA-N | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |